Printed From BioPortfolio.com
Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
18:54 EST 17 Nov 2017 | News-Medical.net
Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.
Original Article: Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
